148 related articles for article (PubMed ID: 32945892)
1. Raptinal silver nanoparticles: new therapeutic advances in hepatocellular carcinoma mouse model.
Taha H; Elfar N; Haffez H; Hassan ZA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):279-289. PubMed ID: 32945892
[TBL] [Abstract][Full Text] [Related]
2. Biological Screening and Radiolabeling of Raptinal as a Potential Anticancer Novel Drug in Hepatocellular Carcinoma Model.
Haffez H; Taha H; Farrag NS; Amin AM; Hassan ZA
Eur J Pharm Sci; 2021 Mar; 158():105653. PubMed ID: 33253882
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
[TBL] [Abstract][Full Text] [Related]
4. Myricetin Selectively Induces Apoptosis on Cancerous Hepatocytes by Directly Targeting Their Mitochondria.
Seydi E; Rasekh HR; Salimi A; Mohsenifar Z; Pourahmad J
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):249-58. PubMed ID: 26919160
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.
Chang W; He W; Li PP; Song SS; Yuan PF; Lu JT; Wei W
Eur J Pharmacol; 2016 Aug; 784():173-80. PubMed ID: 27181068
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
[TBL] [Abstract][Full Text] [Related]
7. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antitumor activity of platinum nanoparticles in the treatment of hepatocellular carcinoma induced in rats.
Medhat A; Mansour S; El-Sonbaty S; Kandil E; Mahmoud M
Tumour Biol; 2017 Jul; 39(7):1010428317717259. PubMed ID: 28720064
[TBL] [Abstract][Full Text] [Related]
9.
Moawed FS; Haroun RA; Abou Zaid ES; Mansour SZ; Badawi AM; Kandil EI
Int J Immunopathol Pharmacol; 2023; 37():3946320231180708. PubMed ID: 37276131
[No Abstract] [Full Text] [Related]
10. Shrimp shells extracted chitin in silver nanoparticle synthesis: Expanding its prophecy towards anticancer activity in human hepatocellular carcinoma HepG2 cells.
Vijayakumar M; Priya K; Ilavenil S; Janani B; Vedarethinam V; Ramesh T; Arasu MV; Al-Dhabi NA; Kim YO; Kim HJ
Int J Biol Macromol; 2020 Dec; 165(Pt A):1402-1409. PubMed ID: 33045301
[TBL] [Abstract][Full Text] [Related]
11. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
Abdel-Hamid NI; El-Azab MF; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
[TBL] [Abstract][Full Text] [Related]
12. Gallium nanoparticles along with low-dose gamma radiation modulate TGF-β/MMP-9 expression in hepatocellular carcinogenesis in rats.
Moawed FS; El-Sonbaty SM; Mansour SZ
Tumour Biol; 2019 Mar; 41(3):1010428319834856. PubMed ID: 30859905
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of alpha-fetoprotein expression inhibits HepG2 cell growth and induces apoptosis.
Yang X; Chen L; Liang Y; Si R; Jiang Z; Ma B; Gao P
J Cancer Res Ther; 2018 Sep; 14(Supplement):S634-S643. PubMed ID: 30249880
[TBL] [Abstract][Full Text] [Related]
14. The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
Li SQ; Wang DM; Zhu S; Ma Z; Li RF; Xu ZS; Han HM
Hum Exp Toxicol; 2015 Nov; 34(11):1053-72. PubMed ID: 25585999
[TBL] [Abstract][Full Text] [Related]
15. Phytofabricated silver nanoparticles of Phyllanthus emblica attenuated diethylnitrosamine-induced hepatic cancer via knock-down oxidative stress and inflammation.
Singh D; Yadav E; Falls N; Kumar V; Singh M; Verma A
Inflammopharmacology; 2019 Oct; 27(5):1037-1054. PubMed ID: 30219979
[TBL] [Abstract][Full Text] [Related]
16. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.
Peng R; Zhao GX; Li J; Zhang Y; Shen XZ; Wang JY; Sun JY
World J Gastroenterol; 2016 Mar; 22(12):3341-54. PubMed ID: 27022216
[TBL] [Abstract][Full Text] [Related]
17. Targeting p53/TRAIL/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats.
Nazmy EA; El-Khouly OA; Zaki MMA; Elsherbiny NM; Said E; Al-Gayyar MMH; Salem HA
Environ Toxicol Pharmacol; 2019 Nov; 72():103240. PubMed ID: 31421311
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma.
Mamdouh AM; Khodeer DM; Tantawy MA; Moustafa YM
Life Sci; 2021 Nov; 285():119961. PubMed ID: 34536497
[TBL] [Abstract][Full Text] [Related]
19. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract][Full Text] [Related]
20. Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
Abdel-Aziz MM; Elshal MF; Abass AT; El-Kafrawy S; Ezzat S; Abdel-Wahab M
Clin Lab; 2016; 62(6):1121-9. PubMed ID: 27468575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
